572 related articles for article (PubMed ID: 20590558)
1. CB2: a cannabinoid receptor with an identity crisis.
Atwood BK; Mackie K
Br J Pharmacol; 2010 Jun; 160(3):467-79. PubMed ID: 20590558
[TBL] [Abstract][Full Text] [Related]
2. Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.
Yang P; Wang L; Xie XQ
Future Med Chem; 2012 Feb; 4(2):187-204. PubMed ID: 22300098
[TBL] [Abstract][Full Text] [Related]
3. The central cannabinoid receptor type-2 (CB2) and chronic pain.
Shang Y; Tang Y
Int J Neurosci; 2017 Sep; 127(9):812-823. PubMed ID: 27842450
[TBL] [Abstract][Full Text] [Related]
4. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.
Maresz K; Pryce G; Ponomarev ED; Marsicano G; Croxford JL; Shriver LP; Ledent C; Cheng X; Carrier EJ; Mann MK; Giovannoni G; Pertwee RG; Yamamura T; Buckley NE; Hillard CJ; Lutz B; Baker D; Dittel BN
Nat Med; 2007 Apr; 13(4):492-7. PubMed ID: 17401376
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid CB(2) receptors in health and disease.
Patel KD; Davison JS; Pittman QJ; Sharkey KA
Curr Med Chem; 2010; 17(14):1393-410. PubMed ID: 20166925
[TBL] [Abstract][Full Text] [Related]
6. CB2 receptor in the CNS: From immune and neuronal modulation to behavior.
Grabon W; Rheims S; Smith J; Bodennec J; Belmeguenai A; Bezin L
Neurosci Biobehav Rev; 2023 Jul; 150():105226. PubMed ID: 37164044
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide.
Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R
J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201
[TBL] [Abstract][Full Text] [Related]
8. The CB
Ji X; Zeng Y; Wu J
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445666
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of the Cannabinoid Receptor Family in Peripheral and Neuro-immune Interactions.
Haugh O; Penman J; Irving AJ; Campbell VA
Curr Drug Targets; 2016; 17(16):1834-1840. PubMed ID: 26758668
[TBL] [Abstract][Full Text] [Related]
10. Knockout controls and the specificity of cannabinoid CB2 receptor antibodies.
Ashton JC
Br J Pharmacol; 2011 Jul; 163(6):1113; author reply 1114. PubMed ID: 21707587
[No Abstract] [Full Text] [Related]
11. Therapeutic potential of cannabinoid receptor ligands: current status.
Singh J; Budhiraja S
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
[TBL] [Abstract][Full Text] [Related]
12. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
Galiègue S; Mary S; Marchand J; Dussossoy D; Carrière D; Carayon P; Bouaboula M; Shire D; Le Fur G; Casellas P
Eur J Biochem; 1995 Aug; 232(1):54-61. PubMed ID: 7556170
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain.
Jhaveri MD; Sagar DR; Elmes SJ; Kendall DA; Chapman V
Mol Neurobiol; 2007 Aug; 36(1):26-35. PubMed ID: 17952647
[TBL] [Abstract][Full Text] [Related]
14. Distribution of the Endocannabinoid System in the Central Nervous System.
Hu SS; Mackie K
Handb Exp Pharmacol; 2015; 231():59-93. PubMed ID: 26408158
[TBL] [Abstract][Full Text] [Related]
15. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
Onaivi ES; Ishiguro H; Gong JP; Patel S; Perchuk A; Meozzi PA; Myers L; Mora Z; Tagliaferro P; Gardner E; Brusco A; Akinshola BE; Liu QR; Hope B; Iwasaki S; Arinami T; Teasenfitz L; Uhl GR
Ann N Y Acad Sci; 2006 Aug; 1074():514-36. PubMed ID: 17105950
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain.
Onaivi ES
Neuropsychobiology; 2006; 54(4):231-46. PubMed ID: 17356307
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptors in microglia of the central nervous system: immune functional relevance.
Cabral GA; Marciano-Cabral F
J Leukoc Biol; 2005 Dec; 78(6):1192-7. PubMed ID: 16204639
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids and intestinal motility: welcome to CB2 receptors.
Izzo AA
Br J Pharmacol; 2004 Aug; 142(8):1201-2. PubMed ID: 15277313
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptors and pain.
Pertwee RG
Prog Neurobiol; 2001 Apr; 63(5):569-611. PubMed ID: 11164622
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
Fernández-Ruiz J; Romero J; Velasco G; Tolón RM; Ramos JA; Guzmán M
Trends Pharmacol Sci; 2007 Jan; 28(1):39-45. PubMed ID: 17141334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
